GTHP

Guided Therapeutics, Inc.

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 11/17/2016
Contact Info
  • 5835 Peachtree Corners East
  • Suite D
  • Norcross, GA 30092

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0000924515
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 3845 - Electromedical equipment
Incorporated In: DE, USA
Year of Inc. 1992
Employees 10 a/o Nov 16, 2016
Company Officers/Contacts
Gene S. Cartwright CEO, CFO
James Clavijo CFO
Bill Wells Director, Corp. Comm.
Company Directors
Michael C. James Chairman
Richard P. Blumberg
Gene S. Cartwright
John E. Immhoff
Company Notes
  • Formerly=SpectRx, Inc. until 5-2008
Service Providers
Accounting/Auditing Firm
UHY LLP
66 South Pearl Street, Suite 401
Albany, 12207
United States

Legal Counsel
Jones Day
1420 Peachtree st.
Atlanta, GA, 30309
United States

Investor Relations Firm
Not Available
GTHP Security Details
Share Structure
Market Value1 $770,454 a/o Dec 08, 2016
Authorized Shares 1,000,000,000 a/o Nov 07, 2016
Outstanding Shares 570,707 a/o Nov 30, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.001
Shareholders
Shareholders of Record 153 a/o Nov 07, 2016
Short Selling Data
Short Interest 360,919 (963.69%)
Oct 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security